Provider
P37-17 Update to Attachment B: Definition of Outpatient Health Services Categories
Program effective Date: Jun 22, 2017
Search Results
Displaying 3111 - 3120 of 3655 results
Provider
P66-17 Clarification of Mid-Level Definitions
Program effective Date: Nov 06, 2017
Provider
P51R1-17 Updated: Accountable Care Organization Product and Network Name Changes
Program effective Date: Nov 15, 2017
Provider
P60-17 2018 Renewal Changes Summary for Institutional Providers
Program effective Date: Nov 01, 2017
Provider
P61-16 New Drug-Related Prior Authorization Criteria for Amitiza and Linzess
Program effective Date: Dec 13, 2016
Provider
P52-16 DHS Guidelines for Mental Health-Targeted Case Management Services for MHCP Subscribers
Program effective Date: Nov 04, 2016
Provider
P63-17 New Drug-Related PA with Quantity Limit Criteria: Otezla (apremilast)
Program effective Date: Nov 06, 2017
Provider
P63-16 Drug Related Prior Authorization Criteria Changes for Ampyra, H.P. Acthar Gel, Transmucosal Fentanyl, Growth Hormone, and Oral Pulmonary Arterial Hypertension Agents
Program effective Date: Dec 20, 2016
Provider
P31-17 New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Thrombopoietin Receptor Agents
Program effective Date: Jun 05, 2017
Provider
P57-17 Addition of Drugs to the Self-Administered Oncology Prior Authorization with Quantity Limit Program
Program effective Date: Oct 24, 2017